This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lohse, M. J. Articles by Engelhardt, S. Search for Related Content PubMed PubMed Citation Articles by Lohse, M. J. Articles by Engelhardt, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cardiomyopathy

(Circulation Research. 2001;89:938.)
© 2001 American Heart Association, Inc.

Editorials

Protein Kinase A Transgenes

The Many Faces of cAMP

Martin J. Lohse, Stefan Engelhardt

From the Institute of Pharmacology, Würzburg, Germany.

Correspondence to Martin J. Lohse, Institute of Pharmacology, Versbacher Str. 9, 97078 Würzburg, Germany. E-mail lohse@toxi.uni-wuerzburg.de

Key Words: protein kinase A • transgenic mouse • ß-adrenergic receptor • adenylyl cyclase

The ß-adrenergic receptor/adenylyl cyclase/protein kinase A (PKA) axis is the central signaling pathway that serves to stimulate cardiac function. It is classically perceived as a linear signaling cascade (Figure), and cAMP is thought to be the second messenger responsible for the positive inotropic, chronotropic, and lusitropic effects of catecholamines. New data gained from a series of transgenic animals overexpressing various elements of this axis show that this system has a far more complex makeup than previously thought.

View larger version (32K): [in this window] [in a new window]   Transgenic models of the cardiac ß-adrenergic receptor/PKA system. The signaling cascade is represented as a simple linear chain. Proteins that are detrimental when overexpressed are shown in black; those causing beneficial effects upon overexpression are depicted in white. PLB indicates phospholamban.

It has been known for about two decades that the ß-adrenergic receptor system is dysfunctional in heart failure.¹ The loss of receptor responsiveness has been attributed to a reduced ß-receptor number, particularly of the ß₁-subtype, plus a functional desensitization of the remaining receptors—presumably mediated via increased activity of G protein–coupled receptor kinases.² The extent of the receptor downregulation and the functional loss correlate with the severity of the disease.^3,4 This phenomenon has long been regarded as detrimental to the compromised function of the failing heart, and it has been proposed that restoration of ß-adrenergic receptor responsiveness might be a strategy to improve cardiac function.

However, recent clinical studies and observations on a panel of transgenic animals suggest that the opposite is the case. Sustained stimulation or overexpression of cardiac . . . [Full Text of this Article]

This article has been cited by other articles:

				L. S Kirschner, Z. Yin, G. N Jones, and E. Mahoney Mouse models of altered protein kinase A signaling Endocr. Relat. Cancer, September 1, 2009; 16(3): 773 - 793. [Abstract] [Full Text] [PDF]

				Z. Yin, G. N. Jones, W. H. Towns II, X. Zhang, E. D. Abel, P. F. Binkley, D. Jarjoura, and L. S. Kirschner Heart-Specific Ablation of Prkar1a Causes Failure of Heart Development and Myxomagenesis Circulation, March 18, 2008; 117(11): 1414 - 1422. [Abstract] [Full Text] [PDF]

				V. O. Nikolaev, V. Boivin, S. Stork, C. E. Angermann, G. Ertl, M. J. Lohse, and R. Jahns A Novel Fluorescence Method for the Rapid Detection of Functional {beta}1-Adrenergic Receptor Autoantibodies in Heart Failure J. Am. Coll. Cardiol., July 31, 2007; 50(5): 423 - 431. [Abstract] [Full Text] [PDF]

				Y. Kitagawa, D. Yamashita, H. Ito, and M. Takaki Reversible effects of isoproterenol-induced hypertrophy on in situ left ventricular function in rat hearts Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H277 - H285. [Abstract] [Full Text] [PDF]

				M. J. Lohse, S. Engelhardt, and T. Eschenhagen What Is the Role of {beta}-Adrenergic Signaling in Heart Failure? Circ. Res., November 14, 2003; 93(10): 896 - 906. [Abstract] [Full Text] [PDF]

				Genetically Modified Animals in Endocrinology Endocr. Rev., August 1, 2003; 24(4): 554 - 555. [Full Text] [PDF]